Discover

News & Info

Quote List Quote List

CSPC PHARMA(01093.HK)

Event Tracking

Mar31

Conerna Pharmaceutical-B and Stone Pharmaceutical Affiliate Reach Phase III Clinical Endpoint for HER2-Positive Breast Cancer Neoadjuvant Therapy

11:05

CMBI Raises Target Price for Stonepharm to HKD 8.7

02:12

Mar27

CMBI Adjusts Profit Forecast and Target Price for Stone Pharmaceutical Group

02:57

ZTE Entertainment and Stone Pharmaceutical Group Announce Latest Shareholder Rights Disclosure

00:06

Mar26

Jefferies Analyst Maintains Sell Rating on Stone Pharmaceutical Group

08:33

Jefferies Releases Report: Stone Pharmaceutical Group's 2022 Performance Under Pressure, Target Price Increased but 'Underperform' Rating Maintained

08:18

Schedules & Filings

Schedules

Filings

Mar25

Earning Release(CST)

FY2025 Q4 Earning Release (HKD) Revenue 6.8 B, Net Income 412.25 M, EPS 0.0361

Distribution Plan(CST)

Cash dividend 0.15 HKD

Nov20

Earning Release(CST)

FY2025 Q3 Earning Release (HKD) Revenue 7.234 B, Net Income 1.053 B, EPS 0.0921

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More